Truncated C-terminus RAD52 alleles have been previously shown to suppress certain germline BRCA2 mutations (Adamson et al., 2020) and the E320* RAD52 truncation also co-occurs with BRCA2 mutations in human cancers (Hamid et al., 2022). This evidence concerns the gene RAD52 and cancer.